EUVIMEDEUVIMED entdecken
Crossref

Novel Function of Osteoprotegerin in the Modulation of Glucose Metabolism in the Liver via mTORC1

Sheng Qiu iD, Xia Wang, Ke Li iD, Siliang Zhang, Yerui Lai, Qiao Mi, Min Yang, Dongfang Liu iD, Ling Li, Qinan Wu iD, Mengliu Yang iD

Diabetes · 2025

DOI: 10.2337/db25-0207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Sheng Qiu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Liver, Glucose, Osteoprotegerin, TOR Serine-Threonine Kinases. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, State Administration of Traditional Chinese Medicine of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoprotegerin (OPG) has emerged as a pivotal factor in metabolic disease pathology; however, its role in hepatic glucose metabolism remains poorly understood. We demonstrated a pronounced reduction in hepatic OPG expression in obese mice, attributable to DNA hypermethylation mediated by DNMT3α. Opg overexpression in the liver reduced the basal metabolic rate and exacerbated glucose metabolism disorders in mice with high-fat diet–induced obesity, whereas Opg knockout yielded opposite effects. Furthermore, mammalian target of rapamycin complex 1 (mTORC1; Raptor)/S6K1/IRS1/AKT signaling was found to be required for the regulation of hepatic glucose metabolism. Mechanistic investigations revealed that OPG interacts with Raptor within the mTORC1 complex, facilitating its phosphorylation at Ser863 and Ser877, influencing the mTORC1 (Raptor)/S6K1/IRS1/AKT signaling pathway, and thereby affecting glucose metabolism and insulin sensitivity. These findings underscore the integral role of OPG in glucose homeostasis and suggest it as a novel therapeutic target in type 2 diabetes. Article Highlights Methylation of the Opg promoter inhibits hepatic OPG expression in obese mice. Hepatic OPG regulates glucose metabolism and insulin sensitivity in obese mice. OPG regulates glucose metabolism through interaction with mammalian target of rapamycin complex 1 (Raptor). Opg deficiency in mice reduces age-related metabolic dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiverGlucoseOsteoprotegerinTOR Serine-Threonine KinasesMultiprotein ComplexesAnimalsMechanistic Target of Rapamycin Complex 1MiceDNA MethylationObesitySignal TransductionMaleInsulin ResistanceMice, KnockoutDiet, High-FatMice, Inbred C57BLRegulatory-Associated Protein of mTORProto-Oncogene Proteins c-akt

Substanzen

Mechanistic Target of Rapamycin Complex 1GlucoseOsteoprotegerinTOR Serine-Threonine KinasesMultiprotein ComplexesRegulatory-Associated Protein of mTORProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Endocrinology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
  • Department of Clinical Biochemistry and Key Laboratory of Laboratory Medical Diagnostics in the Ministry of Education, Chongqing Medical University, Chongqing, China.
  • Department of Endocrinology, People's Hospital of Dazu, Chongqing Medical University, Chongqing, China.

ORCID-Profile: Sheng Qiu, Ke Li, Dongfang Liu, Qinan Wu, Mengliu Yang

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • State Administration of Traditional Chinese Medicine of the People's Republic of China
  • the General project of Chongqing Natural Science Foundation

Zitieren

APA

Qiu, S., Wang, X., Li, K., Zhang, S., Lai, Y., Mi, Q., Yang, M., Liu, D., Li, L., Wu, Q., & Yang, M. (2025). Novel Function of Osteoprotegerin in the Modulation of Glucose Metabolism in the Liver via mTORC1. Diabetes. https://doi.org/10.2337/db25-0207

Vancouver

Qiu S, Wang X, Li K, Zhang S, Lai Y, Mi Q, et al. Novel Function of Osteoprotegerin in the Modulation of Glucose Metabolism in the Liver via mTORC1. Diabetes. 2025. doi:10.2337/db25-0207

BibTeX
@article{Qiu2025,
  author = {Qiu, Sheng and Wang, Xia and Li, Ke and Zhang, Siliang and Lai, Yerui and Mi, Qiao and Yang, Min and Liu, Dongfang and Li, Ling and Wu, Qinan and Yang, Mengliu},
  title = {Novel Function of Osteoprotegerin in the Modulation of Glucose Metabolism in the Liver via mTORC1},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db25-0207}
}
Kostenlos starten →